Organon & Co. (OGN)
13.64
+0.01
(+0.07%)
USD |
NYSE |
Sep 11, 16:00
13.64
0.00 (0.00%)
After-Hours: 20:00
Organon EPS Diluted (Quarterly) : 0.3993 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3993 |
| March 31, 2026 | 0.5554 |
| December 31, 2025 | -0.7879 |
| September 30, 2025 | 0.6138 |
| June 30, 2025 | 0.5574 |
| March 31, 2025 | 0.3333 |
| December 31, 2024 | 0.4194 |
| September 30, 2024 | 1.382 |
| June 30, 2024 | 0.7541 |
| March 31, 2024 | 0.778 |
| December 31, 2023 | 2.128 |
| September 30, 2023 | 0.2262 |
| June 30, 2023 | 0.9455 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.6909 |
| December 31, 2022 | 0.4229 |
| September 30, 2022 | 0.89 |
| June 30, 2022 | 0.9171 |
| March 31, 2022 | 1.364 |
| December 31, 2021 | 0.7967 |
| September 30, 2021 | 1.274 |
| June 30, 2021 | 1.684 |
| March 31, 2021 | 1.574 |
| December 31, 2020 | 1.452 |
| September 30, 2020 | 2.158 |
| June 30, 2020 | 2.138 |
| March 31, 2020 | 2.773 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | -0.5405 |
| Eli Lilly & Co. | 7.939 |
| Pfizer Inc. | -0.0435 |
| Bristol Myers Squibb Co. | 1.620 |
| Crinetics Pharmaceuticals, Inc. (DELISTED) | -1.145 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 108.00M |
| Revenue (Quarterly) | 1.558B |
| Total Expenses (Quarterly) | 1.45B |
| Enterprise Value | 11.00B |
| Gross Profit Margin (Quarterly) | 54.36% |
| Profit Margin (Quarterly) | 6.93% |
| Earnings Yield | 5.72% |
| Operating Earnings Yield | 33.08% |
| Normalized Earnings Yield | 11.10 |